adenosine has been researched along with Hyperlipemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Li, T; Ma, C; Qu, K; Sun, S; Wang, Y; Yang, L; Zhang, J; Zhu, H | 1 |
| Abdalla, FH; Bernardes, VM; Braun, JBS; Casali, EA; Castilhos, LG; da Cruz, IBM; de Andrade, CM; de Oliveira, JS; Leal, DBR; Manzoni, AG; Passos, DF; Ruchel, JB | 1 |
| Jiang, CY; Miao, ZX; Wang, YH; Yang, L; Zhu, HB | 1 |
| Alloosh, M; Edwards, JM; Long, X; Mokelke, EA; Neeb, ZP; Sturek, M | 1 |
| Jiang, C; Lian, Z; Sun, Y; Wang, Y; Zhu, H | 1 |
| Alpert, NM; Fischman, AJ; Gewirtz, H; Huggins, GS; Pasternak, RC | 1 |
| Dayanikli, F; Duvernoy, CS; Graeff, H; Höss, C; Matsunari, I; Meyer, C; Rattenhuber, J; Schwaiger, M; Seifert-Klauss, V | 1 |
| Kitsukawa, S; Komatsu, R; Masuda, Y; Shimada, K; Shiomi, M; Suzuki, K; Tadokoro, H; Takami, A; Tanada, S; Ueda, M; Yoshida, K | 1 |
| Chou, TF; Lee, TM; Su, SF; Tsai, CH | 1 |
| Fisher, NG; Kaul, S; Leong-Poi, H; Lindner, JR; Rim, SJ; Wei, K | 1 |
| Menci, S; Orsucci, PL | 1 |
| Nishino, T | 1 |
1 trial(s) available for adenosine and Hyperlipemia
| Article | Year |
|---|---|
Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine.
Topics: Adenosine; Aminophylline; Analysis of Variance; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Disease; Electrocardiography; Female; Hemodynamics; Humans; Hyperlipidemias; Lactates; Male; Middle Aged; Myocardial Ischemia; Pravastatin | 2001 |
11 other study(ies) available for adenosine and Hyperlipemia
| Article | Year |
|---|---|
Beneficial Metabolic Effects of 2',3',5'-Triacetyl-N
Topics: Adenosine; Animals; Cricetinae; Diet, High-Fat; Gastrointestinal Microbiome; Hyperlipidemias; Magnetic Resonance Spectroscopy; Metabolomics | 2018 |
Lipotoxicity-associated inflammation is prevented by guarana (
Topics: Adenosine; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Inflammation; Lymphocytes; Male; Rats; Rats, Wistar; Simvastatin; Theobromine; Theophylline | 2021 |
Evaluation of dose-related effects of 2', 3', 5'-tri-O-acetyl-N6-(3-hydroxylaniline)adenosine using NMR-based metabolomics.
Topics: Adenosine; Animals; Cricetinae; Hyperlipidemias; Least-Squares Analysis; Lipid Metabolism; Magnetic Resonance Spectroscopy; Metabolomics; Multivariate Analysis; Principal Component Analysis | 2014 |
Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swine.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Cholesterol; Coronary Circulation; Dietary Fats; Gene Expression; Hemodynamics; Hyperlipidemias; Lipoproteins; Male; Microvessels; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; Stents; Swine; Swine, Miniature; Triglycerides; Up-Regulation | 2010 |
Beneficial metabolic effects of 2',3',5'-tri-acetyl-N6- (3-hydroxylaniline) adenosine in the liver and plasma of hyperlipidemic hamsters.
Topics: Adenosine; Animals; Azo Compounds; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Disease Models, Animal; Hyperlipidemias; Liver; Metabolomics; Principal Component Analysis; Triglycerides; Ultrasonography | 2012 |
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse.
Topics: Adenosine; Aged; Coronary Circulation; Coronary Vessels; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Myocardial Ischemia; Simvastatin; Vasodilation | 1998 |
Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects.
Topics: Adenosine; Cholesterol; Coronary Circulation; Coronary Disease; Female; Follow-Up Studies; Heart Rate; Humans; Hyperemia; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Postmenopause; Prognosis; Regional Blood Flow; Rest; Risk Factors; Sex Characteristics; Tomography, Emission-Computed; Triglycerides; Vasodilator Agents | 1999 |
Adenosine-induced coronary flow reserve in Watanabe heritable hyperlipidemic rabbits.
Topics: Adenosine; Animals; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Hemodynamics; Hyperlipidemias; Male; Microspheres; Models, Animal; Rabbits; Tomography, Emission-Computed | 2000 |
Decrease in coronary blood flow reserve during hyperlipidemia is secondary to an increase in blood viscosity.
Topics: Adenosine; Animals; Arterioles; Blood Flow Velocity; Blood Pressure; Blood Viscosity; Blood Volume; Calcium Chloride; Capillary Resistance; Coronary Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Echocardiography; Fat Emulsions, Intravenous; Hyperemia; Hyperlipidemias; Mice; Mice, Inbred C57BL; Microspheres; Muscle, Skeletal; Triglycerides; Venules | 2001 |
[Changes induced by S-adenosylmethionine (SAM) in the cholesterol and triglyceride plasma levels and in the beta-alpha lipoprotein ratio in cases of hyperlipemia. (Preliminary note)].
Topics: Adenosine; Aged; Cholesterol; Female; Humans; Hyperlipidemias; Lipid Mobilization; Lipoproteins; Male; Methionine; Middle Aged; S-Adenosylmethionine; Triglycerides | 1972 |
[Studies on platelet adhesiveness. II. On various diseases].
Topics: Adenosine; Arteriosclerosis; Dextrans; Diabetes Mellitus; Dipyridamole; Female; Fibrinolytic Agents; Humans; Hyperlipidemias; Leukemia, Myeloid, Acute; Male; Platelet Adhesiveness | 1970 |